Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1014 participants.

Also called NCT05728333

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 1,014 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05728333
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05728333. Randomized; double masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2026-05-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke
Acronym
ADJUVANT
Condition
Stroke, Acute Ischemic
Intervention (Drug)
Tirofiban
Intervention (Drug)
Thrombolysis
Lead sponsor
Xinqiao Hospital of Chongqing (class: other)
Collaborator
Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine (class: not stated)

Record details

Record id
cardio:ct-nct05728333
Content hash
9e6daa6c7a1b6e907d5039339075a087f7617fb3978c46ee37df0cadc0a9f422